Accessibility Menu
 

Lite Strategy

(NASDAQ) LITS

Current Price$1.17
Market Cap$42.54M
Since IPO (2003)-100%
5 Year-98%
1 Year-49%
1 Month+6%

Lite Strategy Financials at a Glance

Market Cap

$42.54M

Revenue (TTM)

$0.00

Net Income (TTM)

$39.70M

EPS (TTM)

$-1.74

P/E Ratio

-0.67

Dividend

$0.00

Beta (Volatility)

0.83 (Low)

Price

$1.17

Volume

10,057

Open

$1.18

Previous Close

$1.17

Daily Range

$1.16 - $1.20

52-Week Range

$0.95 - $9.00

LITS News

LITS: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Lite Strategy

Industry

Biotechnology

Employees

4

CEO

Justin Jay File

Headquarters

San Diego, CA 92121, US

LITS Financials

Key Financial Metrics (TTM)

Gross Margin

0%

Operating Margin

0%

Net Income Margin

0%

Return on Equity

-76%

Return on Capital

-15%

Return on Assets

-48%

Earnings Yield

-1.49%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$42.54M

Shares Outstanding

36.36M

Volume

10.06K

Short Interest

0.00%

Avg. Volume

458.80K

Financials (TTM)

Gross Profit

$368.00K

Operating Income

$17.45M

EBITDA

$17.09M

Operating Cash Flow

$20.84M

Capital Expenditure

$0.00

Free Cash Flow

$20.84M

Cash & ST Invst.

$18.01M

Total Debt

$0.00

Lite Strategy Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q2 2026YOY CHG

Revenue

$0.00

N/A

Gross Profit

$0.00

N/A

Gross Margin

0.00%

N/A

Market Cap

$42.54M

N/A

Market Cap/Employee

$10.64M

N/A

Employees

4

N/A

Net Income

$30.80M

-1050.5%

EBITDA

$3.35M

+2.9%

Quarterly Fundamentals

Name
Q2 2026YOY CHG

Net Cash

$8.76M

-63.1%

Accounts Receivable

$0.00

N/A

Inventory

$0.00

N/A

Long Term Debt

$0.00

N/A

Short Term Debt

$0.00

N/A

Return on Assets

-47.87%

N/A

Return on Invested Capital

-14.67%

N/A

Free Cash Flow

$1.93M

+83.2%

Operating Cash Flow

$1.93M

+83.2%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
NTRBNutriband Inc.
$3.69-6.58%
HOWLWerewolf Therapeutics, Inc.
$0.79-2.97%
ACRVAcrivon Therapeutics, Inc. Common Stock
$1.66-2.35%
TCRXTScan Therapeutics, Inc.
$1.04+0.00%

Trending Stocks

Symbol / CompanyPricePrice Chg
CMCSAComcast
$29.02+0.00%
TQQQProShares Trust - ProShares UltraPro Qqq
$43.08-0.06%
RITMRithm Capital
$8.77-0.03%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$7.82+0.06%

Questions About LITS

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.